MLAB Mesa Laboratories Inc.

Mesa Laboratories, Inc. to Announce Third Quarter Results on February 3, 2026

Mesa Laboratories, Inc. to Announce Third Quarter Results on February 3, 2026

LAKEWOOD, Colo., Dec. 03, 2025 (GLOBE NEWSWIRE) --  - Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the third quarter of fiscal year 2026 at approximately 8:00 A.M. Eastern Time (ET) on Tuesday, February 3, 2026.

About Mesa Laboratories

Mesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. Mesa offers products and services to help our customers ensure product integrity, increase patient and worker safety, and improve the quality of life throughout the world.

Mesa Laboratories Contacts

Gary Owens, President and CEO

John Sakys, CFO

1-303-987-8000

For more information about Mesa Laboratories, please visit our website at .



EN
03/12/2025

Underlying

MLABMesa Laboratories Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Mesa Laboratories Inc.

 PRESS RELEASE
Free
MLAB Mesa Laboratori...

Mesa Labs Announces Third Quarter Results

Mesa Labs Announces Third Quarter Results LAKEWOOD, Colo., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (“Mesa” or “the Company”), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results for its third fiscal quarter (“3Q26”) ended December 31, 2025 (amounts in thousands). 3Q26 Financial Summary – (comparisons are versus the same year ago period Revenues increased 3.6%Non-GAAP organic and core organic revenues1 growth was 3.6% and 1.2%, respectivelyNon-GAAP organic revenues growth exclu...

22h / 20m 1 EN
 PRESS RELEASE
Free
MLAB Mesa Laboratori...

MESA LABS DECLARES QUARTERLY DIVIDEND

MESA LABS DECLARES QUARTERLY DIVIDEND LAKEWOOD, Colo., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on March 16, 2026, to shareholders of record at the close of business on February 28, 2026. About Mesa Laboratories, Inc. Mesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the pharm...

January 7, 2026 1 EN
 PRESS RELEASE
Free
MLAB Mesa Laboratori...

Mesa Labs to Present at the 44th Annual J.P. Morgan Healthcare Confere...

Mesa Labs to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026 LAKEWOOD, Colo., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced that Gary Owens, President and CEO, and John Sakys, CFO will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14th, 2026. Management will participate in a Formal Presentation at 4:30 p.m. Pacific Time. A live webcast of the presentation will be accessi...

December 19, 2025 1 EN
 PRESS RELEASE
Free
MLAB Mesa Laboratori...

Mesa Laboratories, Inc. to Announce Third Quarter Results on February ...

Mesa Laboratories, Inc. to Announce Third Quarter Results on February 3, 2026 LAKEWOOD, Colo., Dec. 03, 2025 (GLOBE NEWSWIRE) --  - Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the third quarter of fiscal year 2026 at approximately 8:00 A.M. Eastern Time (ET) on Tuesday, February 3, 2026. About Mesa LaboratoriesMesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. Mesa offers products and se...

December 3, 2025 1 EN
 PRESS RELEASE
Free
MLAB Mesa Laboratori...

Mesa Laboratories, Inc. to Participate in Upcoming Investor Conference...

Mesa Laboratories, Inc. to Participate in Upcoming Investor Conferences LAKEWOOD, Colo., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced that Gary Owens, President and CEO, and John Sakys, CFO will be attending the following upcoming conferences: Raymond James Napa Valley Small Cap SymposiumFormat: 1x1 Meetings Date: Monday, November 17, 2025Jefferies London Healthcare Conference Format: Fireside chatDate: Thursday, November 20, 2025Time: 12:00 p.m. GMTWebcast: 8th Annual Evercore Healthcare ConferenceFormat: Fireside chat Date: Wednesday, Decemb...

November 12, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch